Intuitive Surgical, Inc. (ISRG) Financial Ratios
27 years of historical data (1999–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↓
39.04
↓-32% vs avg
5yr avg: 57.25
30Y Low14.5·High72.7
P/FCF
↑
58.01
↓-49% vs avg
5yr avg: 112.84
30Y Low19.9·High177.9
P/B Ratio
↑
8.22
↓-20% vs avg
5yr avg: 10.29
30Y Low1.4·High14.2
ROE
↑
16.6%
↓+12% vs avg
5yr avg: 14.8%
30Y Low-83%·High25%
Debt/EBITDA
↑
0.08
↑+42% vs avg
5yr avg: 0.06
30Y Low0.0·High0.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ISRG Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Intuitive Surgical, Inc. trades at 51.7x earnings, 30% below its 5-year average of 74.0x, sitting at the 59th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 134%. On a free-cash-flow basis, the stock trades at 58.0x P/FCF, 49% below the 5-year average of 112.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $144.5B | $205.4B | $188.9B | $120.6B | $96.1B | $131.4B | $98.4B | $70.6B | $56.9B | $42.4B | $24.9B |
| Enterprise Value | $141.4B | $202.4B | $187.1B | $117.8B | $94.5B | $130.2B | $96.8B | $69.6B | $56.0B | $38.6B | $20.1B |
| P/E Ratio → | 51.69 | 71.96 | 81.30 | 67.07 | 72.70 | 77.10 | 92.76 | 51.18 | 50.52 | 64.37 | 33.87 |
| P/S Ratio | 14.35 | 20.41 | 22.62 | 16.92 | 15.44 | 23.02 | 22.58 | 15.77 | 15.28 | 13.57 | 9.22 |
| P/B Ratio | 8.22 | 11.45 | 11.43 | 9.00 | 8.64 | 10.95 | 10.06 | 8.51 | 8.51 | 8.98 | 4.31 |
| P/FCF | 58.01 | 82.47 | 144.92 | 160.85 | 100.23 | 75.71 | 86.08 | 60.24 | 57.93 | 44.53 | 25.20 |
| P/OCF | 47.67 | 67.78 | 78.24 | 66.48 | 64.43 | 62.90 | 66.28 | 44.20 | 48.65 | 37.10 | 23.90 |
P/E links to full P/E history page with 30-year chart
ISRG EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Intuitive Surgical, Inc.'s enterprise value stands at 39.0x EBITDA, 32% below its 5-year average of 57.3x. The Healthcare sector median is 14.2x, placing the stock at a 175% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 20.11 | 22.40 | 16.54 | 15.18 | 22.81 | 22.21 | 15.53 | 15.05 | 12.34 | 7.43 |
| EV / EBITDA | 39.04 | 55.86 | 66.55 | 54.32 | 48.63 | 60.91 | 72.65 | 44.18 | 42.47 | 33.57 | 19.42 |
| EV / EBIT | 48.01 | 68.70 | 79.64 | 66.69 | 59.90 | 71.51 | 92.20 | 50.60 | 46.72 | 36.31 | 21.15 |
| EV / FCF | — | 81.24 | 143.48 | 157.18 | 98.58 | 75.02 | 84.66 | 59.31 | 57.05 | 40.49 | 20.31 |
ISRG Profitability
Margins and return-on-capital ratios measuring operating efficiency
Intuitive Surgical, Inc. earns an operating margin of 29.3%. Operating margins have expanded from 24.8% to 29.3% over the past 3 years, signaling improving operational efficiency. ROE of 16.6% indicates solid capital efficiency. ROIC of 15.0% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.0% | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | 65.6% | 69.4% | 69.9% | 70.1% | 69.9% |
| Operating Margin | 29.3% | 29.3% | 28.1% | 24.8% | 25.3% | 31.9% | 24.1% | 30.7% | 32.2% | 33.7% | 35.0% |
| Net Profit Margin | 28.4% | 28.4% | 27.8% | 25.2% | 21.3% | 29.9% | 24.3% | 30.8% | 30.3% | 21.1% | 27.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.6% | 16.6% | 15.5% | 14.7% | 11.4% | 15.6% | 11.7% | 18.4% | 19.8% | 12.6% | 14.6% |
| ROA | 14.5% | 14.5% | 13.6% | 12.7% | 10.0% | 13.8% | 10.1% | 15.7% | 16.6% | 10.8% | 12.9% |
| ROIC | 15.0% | 15.0% | 13.9% | 13.1% | 11.6% | 14.4% | 10.2% | 15.8% | 26.8% | 86.8% | 74.2% |
| ROCE | 16.5% | 16.5% | 15.2% | 13.9% | 13.2% | 16.1% | 11.1% | 17.5% | 20.4% | 20.1% | 18.7% |
ISRG Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Intuitive Surgical, Inc. carries a Debt/EBITDA ratio of 0.1x, which is very conservative (97% below the sector average of 3.2x). The company holds a net cash position — cash of $3.4B exceeds total debt of $303M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.01 | — | — | 0.01 | — | 0.01 | — | — | — |
| Debt / EBITDA | 0.08 | 0.08 | 0.05 | — | — | 0.04 | — | 0.05 | — | — | — |
| Net Debt / Equity | — | -0.17 | -0.11 | -0.21 | -0.14 | -0.10 | -0.17 | -0.13 | -0.13 | -0.81 | -0.84 |
| Net Debt / EBITDA | -0.85 | -0.85 | -0.67 | -1.27 | -0.81 | -0.56 | -1.22 | -0.69 | -0.65 | -3.35 | -4.68 |
| Debt / FCF | — | -1.23 | -1.44 | -3.67 | -1.65 | -0.69 | -1.42 | -0.93 | -0.87 | -4.04 | -4.89 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($3.4B) exceeds total debt ($303M)
ISRG Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Intuitive Surgical, Inc.'s current ratio of 4.87x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 3.96x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 4.76x to 4.87x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.87 | 4.87 | 4.07 | 4.76 | 4.40 | 5.08 | 6.86 | 4.53 | 5.28 | 4.55 | 7.69 |
| Quick Ratio | 3.96 | 3.96 | 3.22 | 4.02 | 3.77 | 4.57 | 6.24 | 3.95 | 4.78 | 4.31 | 7.43 |
| Cash Ratio | 2.96 | 2.96 | 2.30 | 3.15 | 2.90 | 3.68 | 5.36 | 3.13 | 3.73 | 3.73 | 6.82 |
| Asset Turnover | — | 0.49 | 0.44 | 0.46 | 0.48 | 0.42 | 0.39 | 0.46 | 0.47 | 0.54 | 0.42 |
| Inventory Turnover | 1.86 | 1.86 | 1.83 | 1.96 | 2.27 | 2.98 | 2.49 | 2.30 | 2.74 | 3.88 | 4.47 |
| Days Sales Outstanding | — | 59.05 | 59.29 | 64.94 | 62.96 | 57.08 | 60.85 | 57.73 | 66.87 | 59.25 | 58.06 |
ISRG Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Intuitive Surgical, Inc. returns 1.6% to shareholders annually primarily through share buybacks. The earnings yield of 1.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.9% | 1.4% | 1.2% | 1.5% | 1.4% | 1.3% | 1.1% | 2.0% | 2.0% | 1.6% | 3.0% |
| FCF Yield | 1.7% | 1.2% | 0.7% | 0.6% | 1.0% | 1.3% | 1.2% | 1.7% | 1.7% | 2.2% | 4.0% |
| Buyback Yield | 1.6% | 1.1% | 0.0% | 0.3% | 2.7% | 0.0% | 0.1% | 0.4% | 0.0% | 5.4% | 0.2% |
| Total Shareholder Yield | 1.6% | 1.1% | 0.0% | 0.3% | 2.7% | 0.0% | 0.1% | 0.4% | 0.0% | 5.4% | 0.2% |
| Shares Outstanding | — | $363M | $362M | $357M | $362M | $366M | $361M | $359M | $356M | $349M | $354M |
Peer Comparison
Compare ISRG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ISRGYou | $144B | 51.7 | 39.0 | 58.0 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 ZBH | $17B | 24.8 | 9.8 | 11.7 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 GMED | $11B | 20.2 | 17.1 | 18.1 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
 ATRC | $1B | -120.0 | 80.7 | 30.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 ABT | $154B | 11.6 | 16.1 | 24.2 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 JNJ | $550B | 39.4 | 19.1 | 27.7 | 69.1% | 24.9% | 20.1% | 20.7% | 1.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 27 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into ISRG consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ISRG — Frequently Asked Questions
Quick answers to the most common questions about buying ISRG stock.
What is Intuitive Surgical, Inc.'s P/E ratio?
Intuitive Surgical, Inc.'s current P/E ratio is 51.7x. The historical average is 53.8x. This places it at the 59th percentile of its historical range.
What is Intuitive Surgical, Inc.'s EV/EBITDA?
Intuitive Surgical, Inc.'s current EV/EBITDA is 39.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 38.7x.
What is Intuitive Surgical, Inc.'s ROE?
Intuitive Surgical, Inc.'s return on equity (ROE) is 16.6%. The historical average is 7.2%.
Is ISRG stock overvalued?
Based on historical data, Intuitive Surgical, Inc. is trading at a P/E of 51.7x. This is at the 59th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Intuitive Surgical, Inc.'s profit margins?
Intuitive Surgical, Inc. has 66.0% gross margin and 29.3% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Intuitive Surgical, Inc. have?
Intuitive Surgical, Inc.'s Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.